|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
389,580,000 |
Market
Cap: |
51.18(B) |
Last
Volume: |
2,329,383 |
Avg
Vol: |
1,913,313 |
52
Week Range: |
$75.49 - $140.45 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 487 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
216,903 |
279,977 |
305,346 |
572,908 |
Total Sell Value |
$29,188,685 |
$36,914,107 |
$39,804,708 |
$69,867,568 |
Total People Sold |
7 |
10 |
14 |
15 |
Total Sell Transactions |
15 |
27 |
47 |
80 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2021-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,301 |
61,124 |
|
- |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2021-03-08 |
4 |
A |
$0.00 |
$6 |
D/D |
5,634 |
23,712 |
|
- |
|
Blackford Quentin S. |
Chief Operating Officer & CFO |
|
2021-03-08 |
4 |
A |
$0.00 |
$7 |
D/D |
7,491 |
51,674 |
|
- |
|
Regan Barry J. |
EVP Operations |
|
2021-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,301 |
13,508 |
|
- |
|
Abbey Donald |
EVP Quality and Regulatory Aff |
|
2021-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,301 |
55,503 |
|
- |
|
Leach Jacob Steven |
EVP Chief Technology Officer |
|
2021-03-08 |
4 |
A |
$0.00 |
$7 |
D/D |
7,171 |
110,749 |
|
- |
|
Sylvain Jereme M |
SVP, Finance & CAO |
|
2021-03-08 |
4 |
A |
$0.00 |
$5 |
D/D |
5,301 |
16,049 |
|
- |
|
Stern Sadie |
EVP Chief Human Resources Off |
|
2021-03-08 |
4 |
A |
$0.00 |
$6 |
D/D |
5,634 |
13,841 |
|
- |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2021-02-26 |
4 |
AS |
$396.79 |
$198,395 |
D/D |
(500) |
18,078 |
|
12% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2021-02-24 |
4 |
AS |
$404.00 |
$448,440 |
I/I |
(1,110) |
7,763 |
|
9% |
|
Sylvain Jereme M |
SVP, Finance & CAO |
|
2021-02-24 |
4 |
AS |
$404.00 |
$242,400 |
D/D |
(600) |
10,700 |
|
9% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2021-02-23 |
4 |
AS |
$406.98 |
$439,131 |
D/D |
(1,079) |
55,823 |
|
6% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2021-02-19 |
4 |
AS |
$420.01 |
$756,025 |
D/D |
(1,800) |
56,902 |
|
2% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-02-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
10,000 |
121,934 |
|
- |
|
Augustinos Nicholas |
Director |
|
2021-02-16 |
4 |
AS |
$412.03 |
$772,556 |
I/I |
(1,875) |
10,092 |
|
6% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-02-01 |
4 |
AS |
$373.44 |
$4,714,965 |
D/D |
(12,468) |
131,934 |
|
5% |
|
Murphy Patrick Michael |
EVP, Chief Legal Officer |
|
2021-01-27 |
4 |
AS |
$359.70 |
$179,850 |
D/D |
(500) |
18,578 |
|
12% |
|
Pacelli Steven Robert |
EVP Strategy and Corporate Dev |
|
2021-01-22 |
4 |
AS |
$367.47 |
$397,960 |
D/D |
(1,079) |
58,702 |
|
2% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2021-01-22 |
4 |
AS |
$367.51 |
$409,407 |
I/I |
(1,110) |
8,873 |
|
2% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-01-13 |
4 |
AS |
$350.95 |
$2,500,653 |
D/D |
(7,073) |
144,402 |
|
-3% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-01-12 |
4 |
AS |
$359.68 |
$14,465,252 |
D/D |
(39,949) |
151,475 |
|
-5% |
|
Sayer Kevin R |
Chairman, CEO & President |
|
2021-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
75,910 |
191,424 |
|
- |
|
Augustinos Nicholas |
Director |
|
2021-01-06 |
4 |
AS |
$375.00 |
$234,375 |
I/I |
(625) |
11,967 |
|
-13% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2021-01-04 |
4 |
S |
$362.96 |
$4,035,812 |
D/D |
(11,025) |
21,524 |
|
9% |
|
Doubleday Richard |
EVP Chief Commercial Officer |
|
2020-12-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
950 |
32,549 |
|
- |
|
1713 Records found
|
|
Page 15 of 69 |
|
|